The Company has several stock option plans which allow for granting of stock options to employees, executives, and directors. The Company has not granted any stock options since fiscal 2008 and there are currently no stock options outstanding. The Company also has a restricted stock plan that allows for the granting of non-vested shares of common stock to employees and executives and a restricted stock plan that allows for the granting of non-vested shares of common stock to non-employee directors. As of October 29, 2022, 647,668 shares were available for grant under the Company’s various restricted stock plans, of which 584,107 shares were available for grant to executive officers.

Compensation expense was recognized during fiscal 2022 and fiscal 2021 for equity-based grants, based on the grant date fair value of the awards. The fair value of grants of non-vested common stock awards is the stock price on the date of grant.


	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021

Stock-based compensation expense, before tax	$	2,775	$	2,464	$	8,497	$	7,558

Stock-based compensation expense, after tax	$	2,095	$	1,860	$	6,415	$	5,706

Non-vested shares of common stock granted during the thirty-nine week periods ended October 29, 2022 and October 30, 2021 were granted pursuant to the Company’s 2005 Restricted Stock Plan and the Company’s 2008 Director Restricted Stock Plan. Shares granted under the 2005 Plan are typically "performance based" and vest over a period of four years, only upon certification by the Compensation Committee of the Board of Directors that the Company has achieved its pre-established performance targets for the fiscal year. Certain shares granted under the 2005 Plan, however, are "non-performance based" and vest over a period of four years without being subject to the achievement of performance targets. Shares granted under the 2008 Director Plan vest 25% on the date of grant and then in equal portions on each of the first three anniversaries of the date of grant.

A summary of the Company’s stock-based compensation activity related to grants of non-vested shares of common stock for the thirty-nine week period ended October 29, 2022 is as follows:


	Shares	Weighted Average Grant Date Fair Value

Non-Vested - beginning of year	590,462	$	32.20
Granted	366,300	36.52
Forfeited	(3,085)	31.08
Vested	(75,458)	36.95
Non-Vested - end of quarter	878,219	$	33.60